Tirzepatide is a once-weekly, prescription injectable for chronic weight management. Originally developed for type 2 diabetes, it targets two incretin receptors – GIP and GLP-1 – to regulate appetite, slow gastric emptying, and stabilize blood sugar. In eligible adults with obesity or those who are overweight with related health risks, this dual action can reduce
The recently approved under-the-skin injection represents a groundbreaking advancement in the field of chronic weight management. It is specifically designed for adults struggling with general obesity or overweight conditions. This innovative medication offers a promising solution for individuals seeking effective long-term weight control. Administered through a convenient injection, it targets adipose tissue, aiding in the


5-Star Patient Reviews